DK3154513T3 - Sammensætninger, der omfatter elektrohydrodynamisk opnåede fibre til administration af specifikke doseringer af en aktiv substans til hud eller slimhinde - Google Patents
Sammensætninger, der omfatter elektrohydrodynamisk opnåede fibre til administration af specifikke doseringer af en aktiv substans til hud eller slimhinde Download PDFInfo
- Publication number
- DK3154513T3 DK3154513T3 DK15727978.7T DK15727978T DK3154513T3 DK 3154513 T3 DK3154513 T3 DK 3154513T3 DK 15727978 T DK15727978 T DK 15727978T DK 3154513 T3 DK3154513 T3 DK 3154513T3
- Authority
- DK
- Denmark
- Prior art keywords
- electrohydrodynamic
- administrating
- milk
- skin
- active substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D1/00—Treatment of filament-forming or like material
- D01D1/02—Preparation of spinning solutions
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
- D01F6/52—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polymers of unsaturated carboxylic acids or unsaturated esters
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
- D01F6/56—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/88—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2201/00—Cellulose-based fibres, e.g. vegetable fibres
- D10B2201/20—Cellulose-derived artificial fibres
- D10B2201/28—Cellulose esters or ethers, e.g. cellulose acetate
- D10B2201/30—Ethers, e.g. CMC
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2321/00—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D10B2321/08—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of unsaturated carboxylic acids or unsaturated organic esters, e.g. polyacrylic esters, polyvinyl acetate
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2321/00—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D10B2321/12—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
- D10B2331/06—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyethers
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201470342 | 2014-06-10 | ||
DKPA201470815 | 2014-12-22 | ||
PCT/EP2015/062842 WO2015189212A1 (en) | 2014-06-10 | 2015-06-09 | Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3154513T3 true DK3154513T3 (da) | 2020-01-27 |
Family
ID=53373453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15727978.7T DK3154513T3 (da) | 2014-06-10 | 2015-06-09 | Sammensætninger, der omfatter elektrohydrodynamisk opnåede fibre til administration af specifikke doseringer af en aktiv substans til hud eller slimhinde |
Country Status (17)
Country | Link |
---|---|
US (5) | US10052291B2 (da) |
EP (2) | EP3154513B1 (da) |
JP (2) | JP6591536B2 (da) |
KR (2) | KR102185355B1 (da) |
CN (1) | CN107072937A (da) |
AU (2) | AU2015273608C1 (da) |
BR (1) | BR112016028961B1 (da) |
CA (1) | CA2950821C (da) |
DK (1) | DK3154513T3 (da) |
ES (1) | ES2763524T3 (da) |
IL (3) | IL291842A (da) |
MX (2) | MX2016015688A (da) |
MY (1) | MY173739A (da) |
NZ (2) | NZ727975A (da) |
RU (2) | RU2019121301A (da) |
SG (2) | SG11201609881WA (da) |
WO (1) | WO2015189212A1 (da) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ303244B6 (cs) | 2011-01-17 | 2012-06-13 | Elmarco S.R.O. | Nosic pro oromukosální, zejména pro sublingvální aplikaci fyziologicky aktivních látek |
WO2014071182A1 (en) | 2012-11-01 | 2014-05-08 | Massachusetts Institute Of Technology | Directed evolution of synthetic gene cluster |
WO2016079246A1 (en) * | 2014-11-20 | 2016-05-26 | Dermtreat Aps | Bioadhesive films |
CN115418357A (zh) | 2015-07-13 | 2022-12-02 | 皮沃特生物公司 | 改良植物性状的方法及组合物 |
AU2016336328A1 (en) | 2015-10-05 | 2018-04-19 | Massachusetts Institute Of Technology | Nitrogen fixation using refactored nif clusters |
RU2701513C2 (ru) | 2015-11-19 | 2019-09-27 | Афикс Терапьютикс А/С | Фармацевтическая композиция, содержащая электрогидродинамически полученные волокна, композиция, имеющая улучшенное время удержания в месте применения |
WO2018132774A1 (en) | 2017-01-12 | 2018-07-19 | Pivot Bio, Inc. | Methods and compositions for improving plant traits |
BR112019014236A2 (pt) * | 2017-01-23 | 2020-03-17 | Afyx Therapeutics A/S | Método para a fabricação de um produto de duas camadas à base de fibras eletrofiadas |
CA3050026A1 (en) | 2017-01-23 | 2018-07-26 | Afyx Therapeutics A/S | Method for preparing electrospun fibers with a high content of a bioadhesive substance |
CN106667913A (zh) * | 2017-02-13 | 2017-05-17 | 东华大学 | 一种载药pH敏感自组装脂质体的制备方法 |
CN107419432A (zh) * | 2017-08-03 | 2017-12-01 | 东华大学 | 一种双敏感载药纳米纤维膜及其制备方法和应用 |
CN107447366A (zh) * | 2017-08-03 | 2017-12-08 | 东华大学 | 一种pH敏感载药缓释纳米纤维膜及其制备方法和应用 |
CA3078555A1 (en) | 2017-10-06 | 2019-04-11 | Foundry Therapeutics, Inc. | Implantable depots for the controlled release of therapeutic agents |
US11547662B2 (en) | 2017-10-25 | 2023-01-10 | Allero Therapeutics B.V. | Treatment of immune diseases by administration of antigen-specific formulations |
EP3479693A1 (en) * | 2017-11-01 | 2019-05-08 | Everris International B.V. | Sulfide containing polyester coatings for agrochemical composition |
US20210069101A1 (en) | 2018-05-12 | 2021-03-11 | Foundry Therapeutics, Inc. | Implantable polymer depots for the controlled release of therapeutic agents |
CN108998847A (zh) * | 2018-08-25 | 2018-12-14 | 诺斯贝尔化妆品股份有限公司 | 一种活性纳米包裹体静电纺丝纤维膜布的制备方法 |
US20210353532A1 (en) | 2018-08-28 | 2021-11-18 | Foundry Therapeutics 1, Inc. | Devices, systems, and methods for delivering, positioning, and securing polymer depots in situ |
US20210308338A1 (en) | 2018-08-28 | 2021-10-07 | Foundry Therapeutics, Inc. | Polymer implants |
BR112021010947A2 (pt) * | 2018-12-07 | 2021-08-31 | Pivot Bio, Inc. | Composições de polímero com estabilidade aprimorada para produtos microbianos de fixação de nitrogênio |
CA3135760A1 (en) | 2019-04-11 | 2020-10-15 | Foundry Therapeutics, Inc. | Implantable depots for localized, sustained, controlled release of therapeutic agents to treat cancer and related symptoms and conditions |
FI20195397A1 (en) * | 2019-05-14 | 2020-11-15 | Capsamedix Oy | Oral control device for controlled release |
CN112107559B (zh) * | 2019-06-20 | 2023-09-08 | 普济生物科技(台州)有限公司 | 口腔透粘膜药物剂型 |
WO2021050532A1 (en) * | 2019-09-09 | 2021-03-18 | Afyx Therapeutics A/S | Compositions for treating fungal infections |
EP4041190A1 (en) | 2019-10-08 | 2022-08-17 | Afyx Therapeutics A/S | Compositions for the delivery of proteins |
US20230136789A1 (en) | 2020-03-05 | 2023-05-04 | Foundry Therapeutics, Inc. | Polymer implants |
ES2876401B2 (es) * | 2020-05-11 | 2024-04-05 | Bioinicia S L | Parches auto-adhesivos de fibras para la liberación controlada de bioactivos |
ES2962999T3 (es) * | 2021-07-30 | 2024-03-22 | Cannamedical Pharma Gmbh | Parche transmucoso que comprende un cannabinoide y/o un opiáceo |
WO2023094457A1 (en) | 2021-11-23 | 2023-06-01 | Afyx Therapeutics A/S | Mucosal patches and methods of use thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61280423A (ja) | 1985-06-05 | 1986-12-11 | Kiyuukiyuu Yakuhin Kogyo Kk | 口腔内粘膜貼付剤 |
DE4337152A1 (de) * | 1993-10-30 | 1995-05-04 | Merck Patent Gmbh | Verfahren zur Herstellung von wäßrigen Chitosan-Lösungen und -Gelen |
KR100806412B1 (ko) * | 2000-01-28 | 2008-02-21 | 스미스클라인 비참 코포레이션 | 전기방사 약제학적 조성물 |
CA2440770C (en) * | 2001-03-22 | 2010-07-13 | Battelle Memorial Institute | Manufacturing dissolvable dosage forms |
US7309498B2 (en) * | 2001-10-10 | 2007-12-18 | Belenkaya Bronislava G | Biodegradable absorbents and methods of preparation |
US20030017208A1 (en) * | 2002-07-19 | 2003-01-23 | Francis Ignatious | Electrospun pharmaceutical compositions |
KR100564366B1 (ko) * | 2003-11-19 | 2006-04-07 | 재단법인서울대학교산학협력재단 | 나노 섬유형 부직포를 이용한 조직 재생용 차폐막 및 그의 제조 방법 |
JP4526851B2 (ja) * | 2004-03-31 | 2010-08-18 | 明彦 谷岡 | 多糖類のナノスケールの繊維および成形体 |
WO2007001405A2 (en) * | 2004-10-06 | 2007-01-04 | Research Foundation Of Suny | High flux and low fouling filtration media |
US7390760B1 (en) * | 2004-11-02 | 2008-06-24 | Kimberly-Clark Worldwide, Inc. | Composite nanofiber materials and methods for making same |
WO2006106514A2 (en) * | 2005-04-06 | 2006-10-12 | Nicast Ltd. | Electrospun dosage form and method of producing the same |
WO2008069760A1 (en) * | 2006-12-05 | 2008-06-12 | Nanyang Technological University | Three-dimensional porous hybrid scaffold and manufacture thereof |
WO2009031620A1 (ja) | 2007-09-05 | 2009-03-12 | Taiyokagaku Co., Ltd. | 水溶性電界紡糸シート |
US8361492B2 (en) * | 2008-04-29 | 2013-01-29 | Ocugenics, LLC | Drug delivery system and methods of use |
WO2010099292A2 (en) * | 2009-02-25 | 2010-09-02 | North Carolina State University | Biodegradable drug or other active delivery system |
US20110111012A1 (en) * | 2009-11-12 | 2011-05-12 | Hemcon Medical Technologies, Inc. | Nanomaterial wound dressing assembly |
RU2487701C2 (ru) * | 2011-07-26 | 2013-07-20 | Общество с ограниченной ответственностью "Инмед" | Раствор для получения материала на основе хитозана, способ получения гемостатического материала из этого раствора (варианты) и медицинское изделие с использованием волокон на основе хитозана |
US9393216B2 (en) | 2012-11-06 | 2016-07-19 | University Of Washington Through Its Center For Commercialization | Vaginal matrices: nanofibers for contraception and prevention of HIV infection |
EP2813212A1 (en) * | 2013-06-10 | 2014-12-17 | Zentiva, a.s. | Drug formulation using API in nanofibers |
-
2015
- 2015-06-09 JP JP2017517193A patent/JP6591536B2/ja active Active
- 2015-06-09 SG SG11201609881WA patent/SG11201609881WA/en unknown
- 2015-06-09 EP EP15727978.7A patent/EP3154513B1/en active Active
- 2015-06-09 MY MYPI2016704276A patent/MY173739A/en unknown
- 2015-06-09 RU RU2019121301A patent/RU2019121301A/ru unknown
- 2015-06-09 DK DK15727978.7T patent/DK3154513T3/da active
- 2015-06-09 KR KR1020207018017A patent/KR102185355B1/ko active IP Right Grant
- 2015-06-09 CA CA2950821A patent/CA2950821C/en active Active
- 2015-06-09 NZ NZ727975A patent/NZ727975A/en unknown
- 2015-06-09 MX MX2016015688A patent/MX2016015688A/es unknown
- 2015-06-09 RU RU2016151163A patent/RU2695217C2/ru active
- 2015-06-09 AU AU2015273608A patent/AU2015273608C1/en active Active
- 2015-06-09 ES ES15727978T patent/ES2763524T3/es active Active
- 2015-06-09 BR BR112016028961-7A patent/BR112016028961B1/pt active IP Right Grant
- 2015-06-09 IL IL291842A patent/IL291842A/en unknown
- 2015-06-09 US US15/317,306 patent/US10052291B2/en active Active
- 2015-06-09 KR KR1020177000755A patent/KR102127344B1/ko active IP Right Grant
- 2015-06-09 SG SG10201808743VA patent/SG10201808743VA/en unknown
- 2015-06-09 NZ NZ746573A patent/NZ746573A/en unknown
- 2015-06-09 CN CN201580030548.3A patent/CN107072937A/zh active Pending
- 2015-06-09 WO PCT/EP2015/062842 patent/WO2015189212A1/en active Application Filing
- 2015-06-09 EP EP19205743.8A patent/EP3622947A1/en active Pending
-
2016
- 2016-11-17 IL IL249036A patent/IL249036B/en active IP Right Grant
- 2016-11-29 MX MX2021001118A patent/MX2021001118A/es unknown
-
2018
- 2018-07-05 US US16/028,217 patent/US20180325834A1/en not_active Abandoned
-
2019
- 2019-01-22 IL IL264413A patent/IL264413B/en unknown
- 2019-06-26 AU AU2019204518A patent/AU2019204518B2/en active Active
- 2019-09-18 JP JP2019169471A patent/JP6770157B2/ja active Active
-
2021
- 2021-12-15 US US17/552,171 patent/US20220105049A1/en not_active Abandoned
-
2023
- 2023-03-10 US US18/182,026 patent/US20230210784A1/en not_active Abandoned
- 2023-10-30 US US18/385,078 patent/US20240058276A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3154513T3 (da) | Sammensætninger, der omfatter elektrohydrodynamisk opnåede fibre til administration af specifikke doseringer af en aktiv substans til hud eller slimhinde | |
DK3273942T3 (da) | Mikronåleplaster til indgivelse af en aktiv bestanddel til huden | |
DK3714922T3 (da) | Anordning til subkutan indgivelse af flydende lægemiddel | |
DK3639813T3 (da) | Flydende formulering omfattende nikotin til aerosolindgivelse | |
DK3692857T3 (da) | Indretning til levering af hudplejesammensætning | |
DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
DK3139986T3 (da) | System til administration af terapeutisk gas | |
DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
DK3479819T3 (da) | Stabilt væskeformigt farmaceutisk præparat | |
BR112017007123A2 (pt) | derivados de tetrahidroisoquinolina | |
DK3068392T5 (da) | Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme | |
DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
BR112016026879A2 (pt) | Composição farmacêutica líquida | |
DK3162402T3 (da) | Næsespraydyse til anvendelse i medicinsk sprøjte | |
CL2016001313A1 (es) | Formulaciones listas de fertilizante líquido de bifentrina. | |
DK3494962T3 (da) | Flydende inhalationsformulering omfattende RPL554 | |
DK3357491T3 (da) | Farmaceutisk sammensætning til afgivelse af et anionisk medikament | |
DK3197868T3 (da) | N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrol-negative allosteriske modulatorer af nr2b | |
BR112017008125A2 (pt) | redução da viscosidade de formulações farmacêuticas | |
DK3386506T3 (da) | Modulatorer af kv3-kanaler til at behandle smerte | |
DK3569166T3 (da) | Indretning til akut behandling af hjertestop | |
DK3137053T3 (da) | Formuleringer af biologiske lægemidler til intravesikal instillation | |
DK3331495T3 (da) | Flydende polymerleveringssystem til forlænget indgivelse af lægemidler | |
DK3182946T3 (da) | Bufrede adhæsivsammensætninger til hudadhærerende medicinske produkter | |
DK3168214T3 (da) | Substituerede 2-thioxo-imidazolidin-4-oner og spiro- analoger deraf, aktiv anti-canceringrediens, farmaceutisk sammensætning, medicinpræparat, fremgangsmåde til behandling af prostatacancer |